Merck, during a transition year, doled out nearly $30M to its pair of CEOs
With Merck taking the reins from retiring CEO Ken Frazier and handing them to Robert Davis at the exact midway point of 2021, how would the New Jersey-based drugmaker divvy up their pay for the yea